{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:19:41Z","timestamp":1791487181065,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10564-5","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:51:03Z","timestamp":1760111463000},"page":"1489-1497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The challenges of using electronic medical records (EMR) to facilitate guideline-directed medical therapy (GDMT) for patients with heart failure (HF) and chronic kidney disease (CKD)"],"prefix":"10.1007","volume":"30","author":[{"given":"Nihar R.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis Perry","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"6","key":"10564_CR1","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","volume":"95","author":"AA House","year":"2019","unstructured":"House AA, Wanner C, Sarnak MJ et al (2019) Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int 95(6):1304\u20131317. https:\/\/doi.org\/10.1016\/j.kint.2019.02.022","journal-title":"Kidney Int"},{"issue":"4","key":"10564_CR2","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1681\/ASN.2006101159","volume":"18","author":"A Kottgen","year":"2007","unstructured":"Kottgen A, Russell SD, Loehr LR et al (2007) Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 18(4):1307. https:\/\/doi.org\/10.1681\/ASN.2006101159","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10564_CR3","doi-asserted-by":"publisher","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","volume":"75","author":"R Saran","year":"2020","unstructured":"Saran R, Robinson B, Abbott KC et al (2020) US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 75(1):A6\u2013A7. https:\/\/doi.org\/10.1053\/j.ajkd.2019.09.003","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10564_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2215\/CJN.05070511","volume":"7","author":"KB Daratha","year":"2012","unstructured":"Daratha KB, Short RA, Corbett CF et al (2012) Risks of subsequent hospitalization and death in patients with kidney disease. Clin J Am Soc Nephrol 7(3):409. https:\/\/doi.org\/10.2215\/CJN.05070511","journal-title":"Clin J Am Soc Nephrol"},{"key":"10564_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12882-017-0784-2","volume":"18","author":"B Bohlouli","year":"2017","unstructured":"Bohlouli B, Jackson T, Tonelli M, Hemmelgarn B, Klarenbach S (2017) Health care costs associated with hospital acquired complications in patients with chronic kidney disease. BMC Nephrol 18:375. https:\/\/doi.org\/10.1186\/s12882-017-0784-2","journal-title":"BMC Nephrol"},{"issue":"9","key":"10564_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s40265-023-01887-4","volume":"83","author":"J Patel","year":"2023","unstructured":"Patel J, Rassekh N, Fonarow GC et al (2023) Guideline-directed medical therapy for the treatment of heart failure with reduced ejection fraction. Drugs 83(9):747\u2013759. https:\/\/doi.org\/10.1007\/s40265-023-01887-4","journal-title":"Drugs"},{"key":"10564_CR7","doi-asserted-by":"crossref","unstructured":"Dixit NM. Optimizing guideline-directed medical therapies for heart failure with reduced ejection fraction during hospitalization. Published online July 3, 2021.  https:\/\/www.uscjournal.com\/articles\/optimizing-guideline-directed-medical-therapies-heart-failure-reduced-ejection-fraction . Accessed 25 Oct 2023","DOI":"10.15420\/usc.2020.29"},{"issue":"4","key":"10564_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","volume":"72","author":"SJ Greene","year":"2018","unstructured":"Greene SJ, Butler J, Albert NM et al (2018) Medical therapy for heart failure with reduced ejection fraction. J Am Coll Cardiol 72(4):351\u2013366. https:\/\/doi.org\/10.1016\/j.jacc.2018.04.070","journal-title":"J Am Coll Cardiol"},{"issue":"10367","key":"10564_CR9","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa A, Davison B, Chioncel O et al (2022) Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet 400(10367):1938\u20131952. https:\/\/doi.org\/10.1016\/S0140-6736(22)02076-1","journal-title":"Lancet"},{"issue":"2","key":"10564_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/jamacardio.2023.4553","volume":"9","author":"G Cotter","year":"2024","unstructured":"Cotter G, Deniau B, Davison B et al (2024) Optimization of evidence-based heart failure medications after an acute heart failure admission: a secondary analysis of the STRONG-HF randomized clinical trial. JAMA Cardiol 9(2):114\u2013124. https:\/\/doi.org\/10.1001\/jamacardio.2023.4553","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10564_CR11","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1111\/j.1755-5922.2010.00258.x","volume":"30","author":"MA Raebel","year":"2012","unstructured":"Raebel MA (2012) Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther 30(3):e156\u2013e166. https:\/\/doi.org\/10.1111\/j.1755-5922.2010.00258.x","journal-title":"Cardiovasc Ther"},{"key":"10564_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211003683","volume":"12","author":"EA Christofides","year":"2021","unstructured":"Christofides EA, Desai N (2021) Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing. J Prim Care Community Health 12:21501327211003683. https:\/\/doi.org\/10.1177\/21501327211003683","journal-title":"J Prim Care Community Health"},{"issue":"8","key":"10564_CR13","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae119","volume":"8","author":"YC Chen","year":"2024","unstructured":"Chen YC, Tung CH, Yu BH (2024) Dose and time effects of renin\u2013angiotensin inhibitors on patients with advanced stages 4 to 5 of diabetic kidney disease. J Endocr Soc 8(8):bvae119. https:\/\/doi.org\/10.1210\/jendso\/bvae119","journal-title":"J Endocr Soc"},{"issue":"15","key":"10564_CR14","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R et al (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383(15):1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"},{"issue":"2","key":"10564_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"WG Herrington","year":"2023","unstructured":"The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N et al (2023) Empagliflozin in patients with chronic kidney disease. N Engl J Med 388(2):117\u2013127. https:\/\/doi.org\/10.1056\/NEJMoa2204233","journal-title":"N Engl J Med"},{"issue":"24","key":"10564_CR16","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B et al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380(24):2295\u20132306. https:\/\/doi.org\/10.1056\/NEJMoa1811744","journal-title":"N Engl J Med"},{"issue":"6","key":"10564_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","volume":"43","author":"R Agarwal","year":"2022","unstructured":"Agarwal R, Filippatos G, Pitt B et al (2022) Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J 43(6):474\u2013484. https:\/\/doi.org\/10.1093\/eurheartj\/ehab777","journal-title":"Eur Heart J"},{"issue":"23","key":"10564_CR18","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD et al (2020) Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 383(23):2219\u20132229. https:\/\/doi.org\/10.1056\/NEJMoa2025845","journal-title":"N Engl J Med"},{"issue":"24","key":"10564_CR19","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R et al (2021) Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med 385(24):2252\u20132263. https:\/\/doi.org\/10.1056\/NEJMoa2110956","journal-title":"N Engl J Med"},{"issue":"12","key":"10564_CR20","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41591-024-03264-4","volume":"30","author":"M Vaduganathan","year":"2024","unstructured":"Vaduganathan M, Filippatos G, Claggett BL et al (2024) Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes. Nat Med 30(12):3758\u20133764. https:\/\/doi.org\/10.1038\/s41591-024-03264-4","journal-title":"Nat Med"},{"key":"10564_CR21","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2407107","author":"SD Solomon","year":"2024","unstructured":"Solomon SD, McMurray JJV, Vaduganathan M et al (2024) Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. https:\/\/doi.org\/10.1056\/nejmoa2407107","journal-title":"N Engl J Med"},{"issue":"1","key":"10564_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/jamia\/ocaa279","volume":"28","author":"BA Van Dort","year":"2020","unstructured":"Van Dort BA, Zheng WY, Sundar V, Baysari MT (2020) Optimizing clinical decision support alerts in electronic medical records: a systematic review of reported strategies adopted by hospitals. J Am Med Inform Assoc 28(1):177\u2013183. https:\/\/doi.org\/10.1093\/jamia\/ocaa279","journal-title":"J Am Med Inform Assoc"},{"issue":"22","key":"10564_CR23","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.jacc.2022.03.338","volume":"79","author":"L Ghazi","year":"2022","unstructured":"Ghazi L, Yamamoto Y, Riello RJ et al (2022) Electronic alerts to improve heart failure therapy in outpatient practice. J Am Coll Cardiol 79(22):2203\u20132213. https:\/\/doi.org\/10.1016\/j.jacc.2022.03.338","journal-title":"J Am Coll Cardiol"},{"issue":"40","key":"10564_CR24","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1093\/eurheartj\/ehad512","volume":"44","author":"L Ghazi","year":"2023","unstructured":"Ghazi L, Yamamoto Y, Fuery M et al (2023) Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial. Eur Heart J 44(40):4233\u20134242. https:\/\/doi.org\/10.1093\/eurheartj\/ehad512","journal-title":"Eur Heart J"},{"issue":"14","key":"10564_CR25","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jacc.2023.02.005","volume":"81","author":"A Mukhopadhyay","year":"2023","unstructured":"Mukhopadhyay A, Reynolds HR, Phillips LM et al (2023) Cluster-randomized trial comparing ambulatory decision support tools to improve heart failure care. J Am Coll Cardiol 81(14):1303\u20131316. https:\/\/doi.org\/10.1016\/j.jacc.2023.02.005","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10564_CR26","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamacardio.2022.2496","volume":"7","author":"T Ahmad","year":"2022","unstructured":"Ahmad T, Desai NR, Yamamoto Y et al (2022) Alerting clinicians to 1-year mortality risk in patients hospitalized with heart failure: the REVEAL-HF randomized clinical trial. JAMA Cardiol 7(9):905\u2013912. https:\/\/doi.org\/10.1001\/jamacardio.2022.2496","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10564_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/j.ajkd.2020.05.013","volume":"76","author":"CA Peralta","year":"2020","unstructured":"Peralta CA, Livaudais-Toman J, Stebbins M et al (2020) Electronic decision support for management of CKD in primary care: a pragmatic randomized trial. Am J Kidney Dis 76(5):636\u2013644. https:\/\/doi.org\/10.1053\/j.ajkd.2020.05.013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10564_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40780-025-00431-8","volume":"11","author":"A Sonoda","year":"2025","unstructured":"Sonoda A (2025) A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment. J Pharm Health Care Sci 11(1):26. https:\/\/doi.org\/10.1186\/s40780-025-00431-8","journal-title":"J Pharm Health Care Sci"},{"key":"10564_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpi.2023.100189","volume":"14","author":"MdA Islam","year":"2023","unstructured":"Islam MdA, Majumder MdZH, Hussein MdA (2023) Chronic kidney disease prediction based on machine learning algorithms. J Pathol Inform 14:100189. https:\/\/doi.org\/10.1016\/j.jpi.2023.100189","journal-title":"J Pathol Inform"},{"issue":"1","key":"10564_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12882-021-02474-z","volume":"22","author":"H Ilyas","year":"2021","unstructured":"Ilyas H, Ali S, Ponum M et al (2021) Chronic kidney disease diagnosis using decision tree algorithms. BMC Nephrol 22(1):273. https:\/\/doi.org\/10.1186\/s12882-021-02474-z","journal-title":"BMC Nephrol"},{"issue":"4","key":"10564_CR31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s40620-023-01573-4","volume":"36","author":"F Sanmarchi","year":"2023","unstructured":"Sanmarchi F, Fanconi C, Golinelli D, Gori D, Hernandez-Boussard T, Capodici A (2023) Predict, diagnose, and treat chronic kidney disease with machine learning: a systematic literature review. J Nephrol 36(4):1101\u20131117. https:\/\/doi.org\/10.1007\/s40620-023-01573-4","journal-title":"J Nephrol"},{"key":"10564_CR32","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.45039.2","volume":"10","author":"S Albagmi","year":"2021","unstructured":"Albagmi S (2021) The effectiveness of EMR implementation regarding reducing documentation errors and waiting time for patients in outpatient clinics: a systematic review. F1000Res 10:514. https:\/\/doi.org\/10.12688\/f1000research.45039.2","journal-title":"F1000Res"},{"key":"10564_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12911-017-0430-8","volume":"17","author":"JS Ancker","year":"2017","unstructured":"Ancker JS, Edwards A, Nosal S, Hauser D, Mauer E, Kaushal R (2017) Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Med Inform Decis Mak 17:36. https:\/\/doi.org\/10.1186\/s12911-017-0430-8","journal-title":"BMC Med Inform Decis Mak"},{"issue":"11","key":"10564_CR34","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/jamia\/ocy112","volume":"25","author":"EM Powers","year":"2018","unstructured":"Powers EM, Shiffman RN, Melnick ER, Hickner A, Sharifi M (2018) Efficacy and unintended consequences of hard-stop alerts in electronic health record systems: a systematic review. J Am Med Inform Assoc 25(11):1556. https:\/\/doi.org\/10.1093\/jamia\/ocy112","journal-title":"J Am Med Inform Assoc"},{"issue":"10","key":"10564_CR35","doi-asserted-by":"publisher","DOI":"10.2196\/22013","volume":"22","author":"PK Wan","year":"2020","unstructured":"Wan PK, Satybaldy A, Huang L, Holtskog H, Nowostawski M (2020) Reducing alert fatigue by sharing low-level alerts with patients and enhancing collaborative decision making using blockchain technology: scoping review and proposed framework (MedAlert). J Med Internet Res 22(10):e22013. https:\/\/doi.org\/10.2196\/22013","journal-title":"J Med Internet Res"},{"issue":"1","key":"10564_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0039-3402715","volume":"11","author":"JD McGreevey","year":"2020","unstructured":"McGreevey JD, Mallozzi CP, Perkins RM, Shelov E, Schreiber R (2020) Reducing alert burden in electronic health records: state of the art recommendations from four health systems. Appl Clin Inform 11(1):1. https:\/\/doi.org\/10.1055\/s-0039-3402715","journal-title":"Appl Clin Inform"},{"issue":"6","key":"10564_CR37","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s12553-021-00607-w","volume":"11","author":"JM de Oliveira","year":"2021","unstructured":"de Oliveira JM, da Costa CA, Antunes RS (2021) Data structuring of electronic health records: a systematic review. Health Technol 11(6):1219\u20131235. https:\/\/doi.org\/10.1007\/s12553-021-00607-w","journal-title":"Health Technol"},{"issue":"10","key":"10564_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000347","volume":"2","author":"J Sedlakova","year":"2023","unstructured":"Sedlakova J, Daniore P, Horn Wintsch A et al (2023) Challenges and best practices for digital unstructured data enrichment in health research: a systematic narrative review. PLOS Digit Health 2(10):e0000347. https:\/\/doi.org\/10.1371\/journal.pdig.0000347","journal-title":"PLOS Digit Health"},{"issue":"1","key":"10564_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12911-020-01297-6","volume":"20","author":"D Zhang","year":"2020","unstructured":"Zhang D, Yin C, Zeng J, Yuan X, Zhang P (2020) Combining structured and unstructured data for predictive models: a deep learning approach. BMC Med Inform Decis Mak 20(1):280. https:\/\/doi.org\/10.1186\/s12911-020-01297-6","journal-title":"BMC Med Inform Decis Mak"},{"issue":"2","key":"10564_CR40","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.2243","volume":"15","author":"R Agarwal","year":"2013","unstructured":"Agarwal R, Anderson C, Zarate J, Ward C (2013) If we offer it, will they accept? Factors affecting patient use intentions of personal health records and secure messaging. J Med Internet Res 15(2):e2243. https:\/\/doi.org\/10.2196\/jmir.2243","journal-title":"J Med Internet Res"},{"issue":"8","key":"10564_CR41","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jamainternmed.2021.3333","volume":"181","author":"AR Habib","year":"2021","unstructured":"Habib AR, Lin AL, Grant RW (2021) The epic sepsis model falls short\u2014the importance of external validation. JAMA Intern Med 181(8):1040\u20131041. https:\/\/doi.org\/10.1001\/jamainternmed.2021.3333","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10564_CR42","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.7326\/M21-2941","volume":"175","author":"JG Choi","year":"2022","unstructured":"Choi JG, Winn AN, Skandari MR et al (2022) First-line therapy for type 2 diabetes with sodium\u2013glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. Ann Intern Med 175(10):1392\u20131400. https:\/\/doi.org\/10.7326\/M21-2941","journal-title":"Ann Intern Med"},{"issue":"6","key":"10564_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-020-0338-x","volume":"10","author":"RS Vincent","year":"2020","unstructured":"Vincent RS (2020) The high cost of prescription drugs: causes and solutions. Blood Cancer J 10(6):1\u20135. https:\/\/doi.org\/10.1038\/s41408-020-0338-x","journal-title":"Blood Cancer J"},{"issue":"5","key":"10564_CR44","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s10741-023-10325-2","volume":"28","author":"J Malgie","year":"2023","unstructured":"Malgie J, Clephas PRD, Brunner-La Rocca HP, de Boer RA, Brugts JJ (2023) Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy. Heart Fail Rev 28(5):1221\u20131234. https:\/\/doi.org\/10.1007\/s10741-023-10325-2","journal-title":"Heart Fail Rev"},{"issue":"14","key":"10564_CR45","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jacc.2023.02.040","volume":"81","author":"T Ahmad","year":"2023","unstructured":"Ahmad T, Desai NR, Clark KAA (2023) The EHR has exposed an urgent moral imperative to improve heart failure care\u2217. J Am Coll Cardiol 81(14):1317\u20131319. https:\/\/doi.org\/10.1016\/j.jacc.2023.02.040","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10564_CR46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.12997\/jla.2021.10.3.282","volume":"10","author":"S Lee","year":"2021","unstructured":"Lee S, Kim HS (2021) Prospect of artificial intelligence based on electronic medical record. J Lipid Atheroscler 10(3):282\u2013290. https:\/\/doi.org\/10.12997\/jla.2021.10.3.282","journal-title":"J Lipid Atheroscler"},{"key":"10564_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijmedinf.2016.10.004","volume":"97","author":"R Vuokko","year":"2017","unstructured":"Vuokko R, M\u00e4kel\u00e4-Bengs P, Hypp\u00f6nen H, Lindqvist M, Doupi P (2017) Impacts of structuring the electronic health record: results of a systematic literature review from the perspective of secondary use of patient data. Int J Med Inform 97:293\u2013303. https:\/\/doi.org\/10.1016\/j.ijmedinf.2016.10.004","journal-title":"Int J Med Inform"},{"issue":"1","key":"10564_CR48","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1038\/s41598-024-54375-4","volume":"14","author":"SK Ghosh","year":"2024","unstructured":"Ghosh SK, Khandoker AH (2024) Investigation on explainable machine learning models to predict chronic kidney diseases. Sci Rep 14(1):3687. https:\/\/doi.org\/10.1038\/s41598-024-54375-4","journal-title":"Sci Rep"},{"issue":"3","key":"10564_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030568","volume":"12","author":"C Delrue","year":"2024","unstructured":"Delrue C, De Bruyne S, Speeckaert MM (2024) Application of machine learning in chronic kidney disease: current status and future prospects. Biomedicines 12(3):568. https:\/\/doi.org\/10.3390\/biomedicines12030568","journal-title":"Biomedicines"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10564-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10564-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T20:03:50Z","timestamp":1763150630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10564-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10564"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10564-5","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Francis Perry receives research support from the National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Defense, Agency for Healthcare Research and Quality, CSL Vifor Pharma, Amgen, AstraZeneca, Whoop, Inc, Hekaheart, Aura Care, and WndrHLTH. He also provides consulting to Aura Care. Dr. Nihar Desai and Dr. Tariq Ahmad do not have any conflicts of interest to declare in relation to this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}